Drug makers -- Cipla and Lupin -- will be dropped from the index.
The changes are announced by Asia Index, a joint venture between S&P Dow Jones Indices LLC and BSE. The move is a part of Asia Index's semi-annual reconstitution results.
"Effective at the open of Monday, December 18, 2017, ...changes will be made," the index provider noted.
The BSE-100, an index of the top 100 listed companies in the country will see Federal Bank, Grasim Industries, Vakrangee Ltd and Bajaj Holdings & Investment coming in.
Besides, changes have been announced in Sensex 50, Sensex Next 50, BSE 200 and BSE 500, among others.
Grasim Industries, Hindalco Industries, Hindustan Petroleum Corp Ltd (HPCL) will join the Sensex 50 index, replacing Ambuja Cements, Aurobindo Pharma and Bosch.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
